Sage Journals: Discover world-class research

Retricted access

Research article

First published 2010-1

The Promise of Follow-on Biologics to Spur Both Biologic Drug Innovation and Competitive Prices

Michael S. Wroblewski, Elizabeth A. Jex

Journal of Generic Medicines: The Business Journal for the Generic Medicines Sector

Retricted access

Research article

First published 2005-1

Constructing an Immunogenicity Risk Assessment for Follow-On Biologics

Paul Chamberlain, Anthony Mire-Sluis

Journal of Generic Medicines: The Business Journal for the Generic Medicines Sector

Retricted access

Other

First published 2010-3

Coping with the Regulatory Realities of Follow-on Biologics and the Nuances of US and European Regulations

Joel I. Folk, Ross A. Davidson

Therapeutic Innovation & Regulatory Science

Retricted access

Research article

First published 2009-5

A Follow-On Biological Drug is not a Biogeneric: Lessons from Omnitrope and Valtropin

Robert I. Roth, Nicholas M. Fleischer

Journal of Generic Medicines: The Business Journal for the Generic Medicines Sector

Retricted access

Research article

First published 2025-2

Biological Age Affecting Attrition and Tooth Loss in a Follow-up Study

P. Meisel, C. Pink, M. Dörr [...]

Journal of Dental Research

Retricted access

Other

First published 2007-1

Unwanted Immunogenicity: Implications for Follow-on Biologicals

Meenu Wadhwa, Robin Thorpe

Therapeutic Innovation & Regulatory Science

Retricted access

Research article

First published 2012-3

Complex Drugs and Biologics: Scientific and Regulatory Challenges for Follow-on Products

J. Michael Nicholas

Therapeutic Innovation & Regulatory Science

Open access

Letter

First published 2017-3

New onset or worsening of psoriasis following biologic therapy: A case series

Vincenzo Bruzzese, Vincenzo De Francesco, Cesare Hassan [...]

International Journal of Immunopathology and Pharmacology

Retricted access

Research article

First published 2012-9

Patent dispute resolution under the Biologics Price Competition and Innovation Act

Suzanne Drennon Munck

Journal of Generic Medicines: The Business Journal for the Generic Medicines Sector

Open access

Article commentary

First published 2011-09

The National Framework and Consequence Management Guidance Following a Biological Attack

Ellen Raber, Wilthea J. Hibbard, Robert Greenwalt

Health Security

Search results